Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development, manufacturing, and distribution of traditional Chinese medicine and modern pharmaceuticals. Kangmei's core offerings include herbal extracts, health supplements, and innovative drug formulations, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including recognition for its advanced research and development capabilities, positioning it as a trusted name in the market. With a strong focus on integrating traditional practices with modern science, Kangmei continues to enhance its market presence and contribute to the global healthcare landscape.
DitchCarbon Score
How does Kangmei Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kangmei Pharmaceutical Co., Ltd.'s score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kangmei Pharmaceutical Co., Ltd.'s reported carbon emissions
Kangmei Pharmaceutical Co., Ltd., headquartered in China, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. The absence of data suggests that the company may still be in the early stages of formalising its climate strategy or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, Kangmei Pharmaceutical may need to establish clear climate commitments and reduction targets to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kangmei Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
